This paper discusses how in vitro studies can be used to predict drug-drug interactions (DDIs) caused by transporters in the body.
Our Research
Discover our recent findings, catch up with news, and review in-depth resources.
Dive Into the World of Resolian With Our Video Series Featuring Our CEO Patrick Bennett
Explore the history that shaped Resolian and get a sneak peek into our future plans with our new video series…
Alliance Pharma and Drug Development Solutions Are Now Resolian
Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development Solutions, Ltd. (acquired in 2022), today announced…
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma…
How to Build a Comprehensive Response to Client Needs as a CRO
As a CRO, meeting client expectations can be an ongoing challenge. What can organizations do to make sure their research is as effective and efficient as possible?
Pharmacokinetics – Area Under the Curve Calculations
The area under the concentration vs. time curve is a useful description of exposure of drug following administration. There are different ways in which AUC may be calculated…
Introduction to Pharmacokinetics
An understanding of the characteristics of drug exposure following administration and how it relates to safety and efficacy is critical for progressing drug development (e.g. in decision making for drug candidates…
